In the fetal rat, nitrofen induces congenital diaphragmatic hernia (CDH) and pulmonary vascular remodeling similar to what is observed in the human condition. Airway hyperactivity is common in infants with CDH and attributed to the ventilatorinduced airway damage. The purpose of this study was to test the hypothesis that airway smooth muscle mechanical properties are altered in the nitrofen-induced CDH rat model. Lungs from nitrofen-exposed fetuses with hernias (CDH) or intact diaphragm (nitrofen) and untreated fetuses (control) were studied on gestation d 21. The left intrapulmonary artery and bronchi were removed and mounted on a wire myograph, and lung expression, content, and immunolocalization of cyclooxygenases COX-1 and COX-2 were evaluated. Pulmonary artery muscle in the CDH group had significantly (p Ͻ 0.01) lower force generation compared with control and nitrofen groups. In contrast, the same generation bronchial smooth muscle of the CDH and nitrofen groups developed higher force compared with control. Whereas no differences were found in endothelium-dependent pulmonary vascular muscle tone, the epithelium-dependent airway muscle relaxation was significantly decreased (p Ͻ 0.01) in the CDH and nitrofen groups. The lung mRNA levels of COX-1 and COX-2 were increased in the CDH and nitrofen groups. COX-1 vascular and airway immunostaining, as well as COX-1 and COX-2 lung protein content, were increased in the CDH group. This is the first report of airway smooth muscle abnormalities in the nitrofen-induced fetal rat model of CDH. We speculate that congenital airway muscle changes may be present in the human form of this disease. Persistent pulmonary hypertension is commonly associated with CDH. Surgical correction of the diaphragmatic defect does not improve oxygenation (1), and mechanical ventilatory support with high concentrations of inspired oxygen is usually required (2). Infants with this condition surviving the immediate neonatal period have a higher prevalence of airway obstruction (3). This has been attributed to the mechanical ventilatorand oxygen-induced lung injury (4).Nitrofen exposure during gestation results in CDH in the fetal rat (5, 6). Pulmonary vascular smooth muscle of fetuses with nitrofen-induced CDH is known to be less responsive to pharmacologic stimulation and shows abnormal relaxation potential (7). Lung hypoplasia (8) and pulmonary airway branching abnormalities (9) are seen early in gestation in nitrofenexposed rats, suggesting that morphogenetic changes precede the diaphragmatic failure to close. However, little is known about functional changes occurring in the airway smooth muscle of this model.The purpose of the present study was to test the hypothesis that the nitrofen-induced fetal rat model of CDH exhibits abnormal airway smooth muscle contraction and relaxation properties. Our initial studies confirmed the hypothesis and thus we sought to determine the factors responsible for enhanced bronchial smooth muscle contraction. Specifically, we tested the hypothesis that COX ...